Primary and secondary prevention of metabolic and cardiovascular comorbidities in women with polycystic ovary syndrome

被引：3
作者：
Spritzer, Poli Mara [1 ]
机构：
[1] Hosp Clin Porto Alegre, Div Endocrinol, Rua Raniro Barcelos 2350, BR-90035003 Porto Alegre, RS, Brazil
来源：
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA | 2015年 / 37卷 / 01期
关键词：
D O I：
10.1590/SO100-720320140005212
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
[21]   Prevalence of the metabolic syndrome in women with polycystic ovary syndrome [J].
Bregieiro Fernandes Costa, Laura Olinda ;
Ribeiro Viana, Aline de Oliveira ;
de Oliveira, Monica .
REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2007, 29 (01) :10-17
[22]   Prediction of metabolic syndrome in women with polycystic ovary syndrome [J].
Ersan, Firat ;
Arslan, Esra ;
Esmer, Aytul Corbaciglu ;
Aydin, Serdar ;
Gedikbasr, Asuman ;
Gedikbasi, Ali ;
Alkis, Ismat ;
Ark, Cemal .
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2012, 13 (03) :178-183
[23]   Primary and secondary prevention of gestational diabetes by metformin therapy during pregnancy in women with polycystic ovary syndrome. [J].
Glueck, C. J. ;
Pranikoff, J. ;
Aregawi, D. ;
Wang, P. .
JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (02) :S361-S361
[24]   Metabolic and cardiovascular changes in patients with polycystic ovary syndrome [J].
Meden-Vrtovec, E ;
Vrtovec, B ;
Osredkar, J .
Human Reproduction, 2005, :316-320
[25]   Polycystic ovary syndrome: a reproductive and metabolic web of risk, comorbidities, and disease [J].
Bates, G. Wright, Jr. .
FERTILITY AND STERILITY, 2019, 111 (03) :471-472
[26]   Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome [J].
Rasool, Shayaq Ul Abeer ;
Ashraf, Sairish ;
Nabi, Mudasar ;
Rashid, Fouzia ;
Fazili, Khalid Majid ;
Amin, Shajrul .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) :2098-2105
[27]   Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome [J].
Christakou, Charikleia D. ;
Diamanti-Kandarakis, Evanthia .
WOMENS HEALTH, 2008, 4 (06) :583-594
[28]   The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome [J].
Sahin, Yilmaz ;
Unluhizarci, Kursad ;
Yilmazsoy, Ayse ;
Yikilmaz, Ali ;
Aygen, Ercan ;
Kelestimur, Fahrettin .
CLINICAL ENDOCRINOLOGY, 2007, 67 (06) :904-908
[29]   How prevalent is metabolic syndrome in women with polycystic ovary syndrome? [J].
Ricardo Azziz .
Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 (3) :132-133
[30]   Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome [J].
Apridonidze, T ;
Essah, PA ;
Iuorno, MJ ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (04) :1929-1935
12345